PACIFIC BIO CA
PACIFIC BIO CA operates in Diversified Metals & Mining.
PACIFIC BIO CA (P09) - Total Assets
Latest total assets as of June 2024: €1.51 Billion EUR
Based on the latest financial reports, PACIFIC BIO CA (P09) holds total assets worth €1.51 Billion EUR as of June 2024.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
PACIFIC BIO CA - Total Assets Trend (2016–2023)
This chart illustrates how PACIFIC BIO CA’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
PACIFIC BIO CA - Asset Composition Analysis
Current Asset Composition (December 2023)
PACIFIC BIO CA's total assets of €1.51 Billion consist of 42.5% current assets and 57.5% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 10.3% |
| Accounts Receivable | €36.62 Million | 2.1% |
| Inventory | €56.68 Million | 3.3% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €456.98 Million | 26.2% |
| Goodwill | €462.26 Million | 26.5% |
Asset Composition Trend (2016–2023)
This chart illustrates how PACIFIC BIO CA's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: PACIFIC BIO CA's current assets represent 42.5% of total assets in 2023, a decrease from 79.1% in 2016.
- Cash Position: Cash and equivalents constituted 10.3% of total assets in 2023, down from 12.2% in 2016.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 52.0% of total assets, an increase from 0.0% in 2016.
- Asset Diversification: The largest asset category is goodwill at 26.5% of total assets.
PACIFIC BIO CA Competitors by Total Assets
Key competitors of PACIFIC BIO CA based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
MANHATTAN ASSOC
BE:MHT
|
Germany | €698.14 Million |
|
TV BROADCAST
MU:TBCN
|
Germany | €6.25 Billion |
|
FIRST CITIZENS BC A
BE:FC6A
|
Germany | €220.57 Billion |
|
COSTCO WHSL
MU:CTO
|
Germany | €69.83 Billion |
|
GOLDMAN SACHS GROUP - Dusseldorf Stock Exchang
DU:GOS
|
Germany | €1.73 Trillion |
|
BURCKHARDT COMPRE N
MU:B5H
|
Germany | €1.07 Billion |
|
Public Service Company of New Mexico PFD 4.58%
PINK:PNMXO
|
USA | $886.19 Million |
|
2H0
F:2H0
|
Germany | €15.27 Million |
PACIFIC BIO CA - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - PACIFIC BIO CA generates 0.11x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - PACIFIC BIO CA is currently not profitable relative to its asset base.
PACIFIC BIO CA - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 8.01 | 3.45 | 1.52 |
| Quick Ratio | 7.14 | 3.20 | 1.22 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €549.75 Million | € 664.14 Million | € 26.25 Million |
PACIFIC BIO CA - Advanced Valuation Insights
This section examines the relationship between PACIFIC BIO CA's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -1.2% |
| Total Assets | €1.75 Billion |
| Market Capitalization | $14.46K USD |
Valuation Analysis
Below Book Valuation: The market values PACIFIC BIO CA's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: PACIFIC BIO CA's assets decreased by 1.2% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for PACIFIC BIO CA (2016–2023)
The table below shows the annual total assets of PACIFIC BIO CA from 2016 to 2023.
| Year | Total Assets | Change |
|---|---|---|
| 2023-12-31 | €1.75 Billion | -1.19% |
| 2022-12-31 | €1.77 Billion | -11.95% |
| 2021-12-31 | €2.01 Billion | +384.80% |
| 2020-12-31 | €413.98 Million | +179.74% |
| 2019-12-31 | €147.99 Million | -13.09% |
| 2018-12-31 | €170.28 Million | +18.18% |
| 2017-12-31 | €144.08 Million | +4.50% |
| 2016-12-31 | €137.88 Million | -- |